Emotion Regulation Individual Therapy for Adolescents With NSSI - An Open Pilot Study

Karolinska Institutet17 enrolled

Overview

The primary aim is to investigate the effectiveness of Emotion Regulation Individual Therapy for Adolescents (ERITA) who self-harm.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Nonsuicidal Self-Injury

Interventions

Emotion Regulation Individual Therapy for AdolescentsBEHAVIORAL

Eligibility

Sex: ALLMin age: 13 YearsMax age: 17 Years

Medical Language ↔ Plain English

Inclusion Criteria: * a primary diagnosis of NSSI as defined by DSM-5 Section 3 * \< 1 NSSI episode during the past month * at least one parent needs to commit to participate in the parent program Exclusion Criteria: * bipolar disorder I or primary psychosis * severe suicidal ideation * ongoing substance dependence * Insertion/withdrawal of psychopharmacological substances within two months prior to the treatment * other acute primary axis I diagnosis (e.g. anorexia nervosa) that demand treatment in first hand * current life circumstances that would hinder the treatment (i.e. ongoing domestic abuse) * insufficient Swedish language skills * Cocurrent treatment with Mentalization based therapy (MBT) or Dialectical behavioral therapy (DBT)

Locations (1)

Karolinska Institutet

Stockholm, Sweden

Outcomes

Primary Outcomes

Deliberate Self-Harm Inventory - 9 item version

Change from baseline in self-harming behaviors when measures weekly, after 12 weeks and at 6 months after treatment has ended.

Time frame: Baseline (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (12 weeks) and six months follow-up

Secondary Outcomes

Borderline Symptom List Behavior supplement (BSL-supplement)

Change from baseline in self-destructive and risky behaviors when measures weekly, after 12 weeks and at 6 months after treatment has ended.

Time frame: Baseline (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (12 weeks) and six months follow-up

Difficulties in Emotion Regulation Scale -16 item version (DERS-16)

Change from baseline in difficulties in emotion regulation when measures weekly, after 12 weeks and at 6 months after treatment has ended.

Time frame: Baseline (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (12 weeks) and six months follow-up

Diary questionnaire (DQ)

Change from baseline in difficulties in emotion regulation when measures weekly, after 12 weeks and at 6 months after treatment has ended.

Time frame: Baseline (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (12 weeks) and six months follow-up

Difficulties in Emotion Regulation Scale (DERS)

Change from baseline in difficulties in emotion regulation after 12 weeks and at 6 months after treatment has ended.

Time frame: Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.